Index
By TNW
About Index
Trending news
Analyze
Pricing
Sign up or sign in
Celgene Corporation
Work at Celgene Corporation?
Add yourself to this profile
2935
Celgene Corporation
Global biopharmaceutical company. Tweets by Greg Geissman & Julissa Viana. Review our guidelines on our site
Edit Profile
celgene.com
Health Care
>
Medical
Technology
>
Biotechnology
B2c
Founded in
1986
More info
Elsewhere
Companies in the same industry
NuSirt Sciences, Inc
Codiak Biosciences
Batu Biologics
Symbiomix
Arsia Therapeutics
Bioverativ
AmnioLife Corporation
Transplant
Baxter International
Napatech
Alexa global traffic share
Twitter followers
Overview
Investments
30
Portfolio
Acquisitions
8
Apps
6
Add info
All markets
Biotechnology (19)
Health Care (7)
Pharmaceuticals (3)
Therapeutics (3)
Health Diagnostics (2)
Big Data Analytics (1)
Health And Wellness (1)
Medical (1)
Product Development Services (1)
Medical Devices (1)
All countries
United States (20)
Canada (1)
United Kingdom (1)
All company sizes
1-10 (3)
11-50 (10)
51-200 (7)
201-1000 (1)
Sequenta
Biotechnology
Total funding
$41.5M in
4 rounds
from 5 investors
By Celgene
undisclosed deal in Oct, 2014
Exit
Adaptive Biotech
, Jan 7, 2015
NANTHEALTH
Health Care +1
Total funding
$762M in
6 rounds
from 7 investors
By Celgene
$25M Private equity in Jun, 2014
GNS Healthcare
Big Data Analytics +1
Total funding
$30.7M in
5 rounds
from 12 investors
By Celgene
undisclosed deal in Nov, 2016
Acceleron Pharma
Biotechnology
Total funding
$70.3M in
3 rounds
from 12 investors
By Celgene
$30M Series F in Dec, 2011
Human Longevity, Inc
Health and Wellness +1
Total funding
$510M in
3 rounds
from 10 investors
By Celgene
$220M Series B in Apr, 2016
Sutro Biopharma
Biotechnology
Total funding
$78.8M in
5 rounds
from 16 investors
By Celgene
$26M Series D in Dec, 2013
Flexus Biosciences
Total funding
$53.2M in
2 rounds
from 4 investors
By Celgene
$38M Series B in Dec, 2014
Exit
Bristol-Myers Squibb
, Feb 23, 2015
Zymeworks Inc.
Biotechnology
Total funding
$155.8M in
7 rounds
from 14 investors
By Celgene
$61.5M Series A in Jan, 2016
FerroKin BioSciences
Biotechnology
Total funding
$12M in
1 rounds
from 5 investors
By Celgene
$12M Series B in Jun, 2010
Cylene Pharmaceuticals
Biotechnology
Total funding
$44M in
1 rounds
from 8 investors
By Celgene
$44M Series C in Jan, 2007
Agios Pharmaceuticals
Health Care +1
Total funding
$78M in
1 rounds
from 4 investors
By Celgene
$78M Series C in Nov, 2011
Acetylon Pharmaceuticals, Inc.
Biotechnology
Total funding
$115M in
2 rounds
from 2 investors
By Celgene
$100M Private equity in Jul, 2013
Tengion
Biotechnology
Total funding
$33.6M in
1 rounds
from 1 investors
By Celgene
$33.6M Series D in Jul, 2013
Atara Biotherapeutics, Inc.
Biotechnology
Total funding
$52M in
2 rounds
from 13 investors
By Celgene
$13.5M Series B in Jan, 2014
VentiRx Pharmaceuticals
Health Care +2
Total funding
$50.6M in
1 rounds
from 5 investors
By Celgene
$50.6M Series B in Sep, 2014
CRISPR Therapeutics
Biotechnology +1
Total funding
$158M in
3 rounds
from 11 investors
By Celgene
$64M Series B in Apr, 2015
Mirna Therapeutics, Inc.
Health Care +2
Total funding
$41.8M in
1 rounds
from 11 investors
By Celgene
$41.8M Series D in Apr, 2015
FLX Bio, Inc.
Medical +2
Total funding
$50M in
1 rounds
from 4 investors
By Celgene
$50M Series B in Apr, 2016
Agenovir Corporation
Health Care +2
Total funding
$10.6M in
1 rounds
from 3 investors
By Celgene
$10.6M Series A in May, 2016
IDEAYA Biosciences
Health Care +1
Total funding
$46M in
1 rounds
from 6 investors
By Celgene
$46M Series A in May, 2016
Sapience Therapeutics, Inc.
Biotechnology +1
Total funding
$22.5M in
1 rounds
from 4 investors
By Celgene
$22.5M Series A in Jul, 2016
Cleave Biosciences
Biotechnology
Total funding
$81M in
2 rounds
from 11 investors
By Celgene
$37M Series B in Aug, 2016
Oncorus, inc
Total funding
$57M in
1 rounds
from 7 investors
By Celgene
$57M Series A in Jul, 2016
Arcus Biosciences
Biotechnology
Total funding
$70M in
1 rounds
from 9 investors
By Celgene
$70M Series B in Sep, 2016
Arrakis Therapeutics
Biotechnology +1
Total funding
$38M in
1 rounds
from 6 investors
By Celgene
$38M Series A in Feb, 2017
Want to see the complete list?
Go Pro!
NuSirt Sciences, Inc
Codiak Biosciences
Batu Biologics
Symbiomix
Bioverativ
AmnioLife Corporation
Transplant
Baxter International
Napatech
